These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 16234441

  • 1. Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease.
    Li B, Yang P, Zhou H, Huang X, Jin H, Chu L, Gao Y, Zhu L, Kijlstra A.
    Br J Ophthalmol; 2005 Nov; 89(11):1410-2. PubMed ID: 16234441
    [Abstract] [Full Text] [Related]

  • 2. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease].
    Liu YX, Wang H, Peng XY, Zhou ZC.
    Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1015-9. PubMed ID: 20137421
    [Abstract] [Full Text] [Related]

  • 3. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
    Commodaro AG, Peron JP, Genre J, Arslanian C, Sanches L, Muccioli C, Rizzo LV, Belfort R.
    Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073
    [Abstract] [Full Text] [Related]

  • 4. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
    Chi W, Yang P, Li B, Wu C, Jin H, Zhu X, Chen L, Zhou H, Huang X, Kijlstra A.
    J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
    [Abstract] [Full Text] [Related]

  • 5. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease.
    Wang C, Tian Y, Lei B, Xiao X, Ye Z, Li F, Kijlstra A, Yang P.
    Invest Ophthalmol Vis Sci; 2012 Jul 10; 53(8):4668-75. PubMed ID: 22669715
    [Abstract] [Full Text] [Related]

  • 6. Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment.
    Ye Z, Wang C, Tang J, Zhou Y, Bai L, Liu Y, Kijlstra A, Yang P.
    J Interferon Cytokine Res; 2015 Apr 10; 35(4):265-72. PubMed ID: 25343528
    [Abstract] [Full Text] [Related]

  • 7. Effect of treatment of rheumatoid arthritis with infliximab on IFN gamma, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity.
    Kawashima M, Miossec P.
    Ann Rheum Dis; 2005 Mar 10; 64(3):415-8. PubMed ID: 15286007
    [Abstract] [Full Text] [Related]

  • 8. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease.
    Imai Y, Sugita M, Nakamura S, Toriyama S, Ohno S.
    Curr Eye Res; 2001 Apr 10; 22(4):312-8. PubMed ID: 11462171
    [Abstract] [Full Text] [Related]

  • 9. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease.
    Sun M, Yang P, Du L, Yang Y, Ye J.
    PLoS One; 2014 Apr 10; 9(4):e93214. PubMed ID: 24690905
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease.
    Li F, Yang P, Liu X, Wang C, Hou S, Kijlstra A.
    Arch Ophthalmol; 2010 Nov 10; 128(11):1449-54. PubMed ID: 21060047
    [Abstract] [Full Text] [Related]

  • 11. T-bet expression is upregulated in active Behçet's disease.
    Li B, Yang P, Zhou H, Zhang Z, Xie C, Lin X, Huang X, Kijlstra A.
    Br J Ophthalmol; 2003 Oct 10; 87(10):1264-7. PubMed ID: 14507763
    [Abstract] [Full Text] [Related]

  • 12. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.
    Peng Z, Jiang S, Wu M, Zhou X, Wang Q.
    Mol Vis; 2017 Oct 10; 23():538-547. PubMed ID: 28761327
    [Abstract] [Full Text] [Related]

  • 13. Increased IL-7 expression in Vogt-Koyanagi-Harada disease.
    Yang Y, Xiao X, Li F, Du L, Kijlstra A, Yang P.
    Invest Ophthalmol Vis Sci; 2012 Feb 27; 53(2):1012-7. PubMed ID: 22247488
    [Abstract] [Full Text] [Related]

  • 14. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L, Yang P, Zhou H, He H, Ren X, Chi W, Wang L, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2008 Aug 27; 49(8):3475-82. PubMed ID: 18421089
    [Abstract] [Full Text] [Related]

  • 15. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion.
    Liu L, Yang P, He H, Lin X, Jiang L, Chi W, Zhao C, Zhou H.
    Br J Ophthalmol; 2008 Apr 27; 92(4):557-61. PubMed ID: 18245271
    [Abstract] [Full Text] [Related]

  • 16. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
    Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, Kalil J, Yamamoto JH.
    Invest Ophthalmol Vis Sci; 2005 Jul 27; 46(7):2465-71. PubMed ID: 15980237
    [Abstract] [Full Text] [Related]

  • 17. Increased Expression of IL-23 Receptor (IL-23R) in Vogt-Koyanagi-Harada (VKH) Disease.
    Wang C, Wang L, Hu J, Li H, Kijlstra A, Yang P.
    Curr Eye Res; 2018 Nov 27; 43(11):1369-1373. PubMed ID: 29877734
    [Abstract] [Full Text] [Related]

  • 18. Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.
    Yi X, Yang P, Sun M, Yang Y, Li F.
    Mol Vis; 2011 Mar 09; 17():673-9. PubMed ID: 21403851
    [Abstract] [Full Text] [Related]

  • 19. Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease.
    Yi S, Chang R, Hu J, Qiu Y, Wang Q, Cao Q, Yuan G, Su G, Zhou C, Wang Y, Kijlstra A, Yang P.
    Invest Ophthalmol Vis Sci; 2018 Sep 04; 59(11):4662-4669. PubMed ID: 30267088
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of rapamycin and dexamethasone on production of IL-17 and IFN-gamma in Vogt-Koyanagi-Harada patients.
    Yang K, Wen J, Liu X, Kijlstra A, Chen L, Chi W, Zhou H, Huang X, Yang P.
    Br J Ophthalmol; 2009 Feb 04; 93(2):249-53. PubMed ID: 19019941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.